FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharmaceutical Industries Sulfamethoxazole and Trimethoprim Tablets Recall

Sulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg, Rx Only, 500-count bottle…

Sun Pharmaceutical Industries, Inc. · Cranbury, NJ

Risk level
Class II
Reported by FDA
May 23, 2018
Recall ID
D-0802-2018
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Sulfamethoxazole and Trimethoprim Tablets starting Apr 19, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0802-2018 on May 23, 2018. Reason: Presence of Foreign Substance:Sun Pharma is recalling one (1) lot of Sulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg (500 ct.) because a foreign matter identified as polyethylene was detected in two (2) tablets. Status: Terminated.

Why it was recalled

Presence of Foreign Substance:Sun Pharma is recalling one (1) lot of Sulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg (500 ct.) because a foreign matter identified as polyethylene was detected in two (2) tablets.

Product description

Sulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg, Rx Only, 500-count bottle, Mfg. by: Frontida BioPharm, Inc., 1100 Orthodox St., Philadelphia, PA 19124, Dist, by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. NDC 53489-146-05

Lot numbers, UPCs & expiration codes

Lot 6848501, EXP 04/2020

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0802-2018
Classification
Class II
Status
Terminated
Recall initiated
Apr 19, 2018
FDA report date
May 23, 2018
Quantity
1,908 500-count bottles
Recalling firm
Sun Pharmaceutical Industries, Inc.

Original FDA data

Every field from FDA enforcement report D-0802-2018, exactly as published.

Show all FDA fields
City
Cranbury
State
NJ
Status
Terminated
Country
United States
Event ID
79909
Address
270 Prospect Plains Rd
Code information
Lot 6848501, EXP 04/2020
Postal code
08512-3605
Report date
May 23, 2018
Product type
Drugs
Recall number
D-0802-2018
Classification
Class II
Recalling firm
Sun Pharmaceutical Industries, Inc.
Product quantity
1,908 500-count bottles
Termination date
Feb 28, 2019
Reason for recall
Presence of Foreign Substance:Sun Pharma is recalling one (1) lot of Sulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg (500 ct.) because a foreign matter identified as polyethylene was detected in two (2) tablets.
Product description
Sulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg, Rx Only, 500-count bottle, Mfg. by: Frontida BioPharm, Inc., 1100 Orthodox St., Philadelphia, PA 19124, Dist, by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. NDC 53489-146-05
Distribution pattern
Nationwide in the USA
Recall initiation date
Apr 19, 2018
Initial firm notification
Letter
Center classification date
May 11, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0802-2018, published May 23, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls